Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS.
Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS.
复制标题
DOI:
10.1136/thoraxjnl-2017-211280
复制
发表时间:
2018-09
期刊:
影响因子:
10
通讯作者:
Ware LB
中科院分区:
文献类型:
--
作者:
Warren MA;Zhao Z;Koyama T;Bastarache JA;Shaver CM;Semler MW;Rice TW;Matthay MA;Calfee CS;Ware LB
There is no accurate, non-invasive measurement to estimate the degree of pulmonary edema in ARDS. We developed the Radiographic Assessment of Lung Edema (RALE) score to evaluate the extent and density of alveolar opacities on chest radiographs. After first comparing the RALE score to gravimetric assessment of pulmonary edema in organ donors, we then evaluated the RALE score in ARDS patients for its relationship to oxygenation and clinical outcomes. We compared radiographs with excised lung weights from 72 organ donors (derivation cohort) and radiographs with clinical data from 174 ARDS patients in the ARDSNet Fluid and Catheter Treatment Trial (validation cohort). To calculate RALE, each radiographic quadrant was scored for extent of consolidation (0–4) and density of opacification (1–3). The product of the consolidation and density scores for each of the four quadrants was summed (maximum score=48). Agreement between two independent reviewers for RALE score was excellent (intra-class correlation coefficient=0.93, 95% CI:0.91–0.95). In donors, pre-procurement RALE score correlated with height-adjusted total lung weight (ρ=0.59, p<0.001). In ARDS patients, higher RALE scores were independently associated with lower PaO2/FiO2 and worse survival. Conservative fluid management significantly decreased RALE score over 3 days compared to liberal fluid management. The RALE score can be used to assess both the extent of pulmonary edema and the severity of ARDS, by utilizing information that is already obtained routinely, safely, and inexpensively in every ARDS patient. This novel non-invasive measure should be useful for assessing ARDS severity and monitoring response to therapy.
登录
查看更多内容
影响因子:
9.6
作者:
HALPERIN, BD;FEELEY, TW;BLANK, NE
通讯作者:
BLANK, NE
影响因子:
2.1
作者:
Ware, Lorraine B.;Neyrinck, Arne;Matthay, Michael A.
通讯作者:
Matthay, Michael A.
影响因子:
158.5
作者:
Papazian, Laurent;Forel, Jean-Marie;Roch, Antoine
通讯作者:
Roch, Antoine
DOI:
10.1111/ajt.12564
发表时间:
2014-03
期刊:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子:
--
作者:
Ware LB;Landeck M;Koyama T;Zhao Z;Singer J;Kern R;Neidlinger N;Nguyen J;Johnson E;Janz DR;Bernard GR;Lee JW;Matthay MA;California Transplant Donor Network
通讯作者:
California Transplant Donor Network
影响因子:
2.5
作者:
Wallet, Florent;Delannoy, Bertrand;Guerin, Claude
通讯作者:
Guerin, Claude